Back to Search

CIARA JUNE, MD

MD

Pediatrics Physician

NPI: 1851140065Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

R81910(AZ)

Research & Publications (20)

Mitochondrial DNA sequence variation in the Boyko, Hutsul, and Lemko populations of the Carpathian highlands.
PMID 19589018·Hum Biol·2009
8-other
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
PMID 19509133·Clin Cancer Res·2009
3-trial
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.
PMID 19211796·Proc Natl Acad Sci U S A·2009
7-preclinical
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.
PMID 19259065·Mol Ther·2009
8-other
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.
PMID 19384291·Mol Ther·2009
7-preclinical
Human T regulatory cell therapy: take a billion or so and call me in the morning.
PMID 19464988·Immunity·2009
6-review
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.
PMID 18587387·Nat Biotechnol·2008
7-preclinical
Genetic engineering of T cells for adoptive immunotherapy.
PMID 18841331·Immunol Res·2008
6-review
Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells.
PMID 18818761·PLoS One·2008
7-preclinical
Immunotherapy opportunities in ovarian cancer.
PMID 18279065·Expert Rev Anticancer Ther·2008
6-review
Post-transplant adoptive T-cell immunotherapy.
PMID 18790452·Best Pract Res Clin Haematol·2008
6-review
CD28 costimulation is essential for human T regulatory expansion and function.
PMID 18684977·J Immunol·2008
7-preclinical
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin.
PMID 18424697·J Immunol·2008
8-other
Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells.
PMID 18511345·Clin Immunol·2008
8-other
Adoptive immunotherapy: good habits instilled at youth have long-term benefits.
PMID 18949448·Immunol Res·2008
6-review
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.
PMID 18559619·Clin Cancer Res·2008
7-preclinical
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.
PMID 18997777·Nat Med·2008
8-other
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.
PMID 18227839·Mol Ther·2008
8-other
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
PMID 18645038·Blood·2008
7-preclinical
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma.
PMID 18076766·J Transl Med·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1625 N CAMPBELL AVE
TUCSON, AZ 85719

Location

Practice Location

1625 N CAMPBELL AVE, TUCSON, AZ
(520) 694-0111

Quick Facts

NPI
1851140065
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile